A new, sensitive, precise, simple, and stability indicating RP-HPLC method is developed and validated for simultaneous estimation of Ceftazidime pentahydrate(CFZ) and its impurity product Pyridine(PY) in powder which is used for making solution in vial for intramuscular (IM) & intravenous (IV) injections. The RP-HPLC method is performed on the Atlantis dc18 column (150 mm X 4.6 mm, 5μm particle size, using buffer solution of pH 7.0 containing 0.02 M anhydrous sodium acetate: acetonitrile (60:40 v/v) as the mobile phase at a flow rate of 1.5 mL/min, injection volume 20 µL and UV detection at 254 nm. The total run time is 5.0 min.Linear relationships are obtained in the ranges of 100-400 µg/ mL and 5-50µg/mL for CFZ and PY, respectively, with significantly different R t values of 1.456and 2.970min for the two studied drugs. Correlation coefficients (r) >0.9999, limits of detection 3.40 and 0.16 µg mL -1 and limits of quantitation of 10.33 and 0.49 µg mL -1 have been obtained for CFZ and PY, respectively. The suggested method is validated according to ICH guidelines. Hence it is suitable for laboratory control of starting materials, bulk and finished products.